Skip to main content
Search
Main Navigation
Home
News
Current Index
Topics
Research leaders
Supplements
Further analysis
Client
services
About
×
Search category
Institutions
Countries/territories
Topics
Article
Search
Search
Search
Search
Time frame: 1 June 2025 - 30 May 2026
Institution search supports local language names.
(Examples: Universidad Autónoma de Madrid
,
筑波大学)
View the latest institution rankings
View the latest Country/territory rankings
View topics
Home
Articles
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
Journal:
The New England Journal of Medicine
Published:
2026-05-30
DOI
:
10.1056/nejmoa2604461
Affiliations:
30
Authors:
30
Go to article
Institutions
Authors
Share
University Hospital Nantes (CHU de Nantes), France
1.000000
0.03
Dizal Pharmaceutical Co., Ltd., China
1.000000
0.03
Careggi University Hospital (AOUC), UNIFI, Italy
1.000000
0.03
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
1.000000
0.03
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
1.000000
0.03
Tianjin Medical University Cancer Institute and Hospital, TMU, China
1.000000
0.03
Shanghai East Hospital, Tongji University, China
1.000000
0.03
Zhejiang Cancer Hospital (ZJCH), China
1.000000
0.03
Foch Hospital, France
1.000000
0.03
Jinan Central Hospital, China
1.000000
0.03
The First Hospital of China Medical University, China
1.000000
0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.03
University Hospital of Modena, Italy
1.000000
0.03
Shandong Cancer Hospital, China
1.000000
0.03
Hôpital Nord, France
1.000000
0.03
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
1.000000
0.03
Alps Grenoble University Hospital (CHU Grenoble Alpes), France
1.000000
0.03
Zhongshan Hospital, Fudan University, China
1.000000
0.03
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA)
1.000000
0.03
Institute of Cancer of São Paulo (ICESP), Brazil
1.000000
0.03
Peking Union Medical College Hospital (PUMCH), China
1.000000
0.03
Princess Margaret Cancer Centre, U of T, Canada
1.000000
0.03
Harbin Medical University Cancer Hospital, China
1.000000
0.03
Clínica Universidad de Navarra (CUN), UNAV, Spain
1.000000
0.03
Peter MacCallum Cancer Centre (Peter Mac), Australia
1.000000
0.03
Beijing Cancer Hospital / School of Oncology, PKUHSC, China
1.000000
0.03
The First Affiliated Hospital, GMU, China
1.000000
0.03
Gazi University, Turkey
1.000000
0.03
Ohio State University Wexner Medical Center (OSUWMC), United States of America (USA)
1.000000
0.03
Institute of Cancer Research (ICO), France
1.000000
0.03
News
News home
News
Comment
Data insights
Dataviz
Careers
Q+A
Archive
Current Index
Institution rankings
Institution benchmarking
Institution collaboration
Country/territory rankings
Country/territory benchmarking
Country/territory collaboration
Data visualizations
Articles
Research highlights
Data products survey
Topics
Topic explorer
Nature Index topics
Leading institutions by topic
Leading countries/territories by topic
Research leaders
Research leaders home
2026 Research Leaders
2025 Research Leaders
2024 Research Leaders
2023 Research Leaders
2022 Research Leaders
2021 Research Leaders
2020 Research Leaders
2019 Research Leaders
2018 Research Leaders
2017 Research Leaders
2016 Research Leaders
Supplements
Nature Index supplements
Further analysis
Author gender ratio
Applied sciences
Nature Strategy Reports
Client services
Client services
Advertising
Research management
Brochure
About
Mission statement
A brief guide to the Nature Index
How to use the Nature Index
FAQ
About Nature Research Intelligence Topics
Institutions A-Z
Glossary of terms
Follow us on Twitter
Follow us on Facebook